Table of Contents

2019-2024 Global Exosome Diagnostics and Therapeutics Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Exosome Diagnostics and Therapeutics Market Size 2014-2024
2.1.2 Exosome Diagnostics and Therapeutics Market Size CAGR by Region
2.2 Exosome Diagnostics and Therapeutics Segment by Type
2.2.1 Instrument
2.2.2 Reagent
2.2.3 Software
2.3 Exosome Diagnostics and Therapeutics Market Size by Type
2.3.1 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2014-2019)
2.3.2 Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Type (2014-2019)
2.4 Exosome Diagnostics and Therapeutics Segment by Application
2.4.1 Diagnostic
2.4.2 Therapeutic
2.5 Exosome Diagnostics and Therapeutics Market Size by Application
2.5.1 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2014-2019)
2.5.2 Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Application (2014-2019)

3 Global Exosome Diagnostics and Therapeutics by Players
3.1 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Players
3.1.1 Global Exosome Diagnostics and Therapeutics Market Size by Players (2017-2019)
3.1.2 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Players (2017-2019)
3.2 Global Exosome Diagnostics and Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Exosome Diagnostics and Therapeutics by Regions
4.1 Exosome Diagnostics and Therapeutics Market Size by Regions
4.2 Americas Exosome Diagnostics and Therapeutics Market Size Growth
4.3 APAC Exosome Diagnostics and Therapeutics Market Size Growth
4.4 Europe Exosome Diagnostics and Therapeutics Market Size Growth
4.5 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Growth

5 Americas
5.1 Americas Exosome Diagnostics and Therapeutics Market Size by Countries
5.2 Americas Exosome Diagnostics and Therapeutics Market Size by Type
5.3 Americas Exosome Diagnostics and Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Exosome Diagnostics and Therapeutics Market Size by Countries
6.2 APAC Exosome Diagnostics and Therapeutics Market Size by Type
6.3 APAC Exosome Diagnostics and Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Exosome Diagnostics and Therapeutics by Countries
7.2 Europe Exosome Diagnostics and Therapeutics Market Size by Type
7.3 Europe Exosome Diagnostics and Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Exosome Diagnostics and Therapeutics by Countries
8.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type
8.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Exosome Diagnostics and Therapeutics Market Forecast
10.1 Global Exosome Diagnostics and Therapeutics Market Size Forecast (2019-2024)
10.2 Global Exosome Diagnostics and Therapeutics Forecast by Regions
10.2.1 Global Exosome Diagnostics and Therapeutics Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Exosome Diagnostics and Therapeutics Forecast by Type
10.8 Global Exosome Diagnostics and Therapeutics Forecast by Application

11 Key Players Analysis
11.1 Aethlon Medical(US)
11.1.1 Company Details
11.1.2 Exosome Diagnostics and Therapeutics Product Offered
11.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Aethlon Medical(US) News
11.2 Exosome Diagnostics(US)
11.2.1 Company Details
11.2.2 Exosome Diagnostics and Therapeutics Product Offered
11.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Exosome Diagnostics(US) News
11.3 NanoSomix Inc.(US)
11.3.1 Company Details
11.3.2 Exosome Diagnostics and Therapeutics Product Offered
11.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 NanoSomix Inc.(US) News
11.4 Thermo Fisher Scientific (US)
11.4.1 Company Details
11.4.2 Exosome Diagnostics and Therapeutics Product Offered
11.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Thermo Fisher Scientific (US) News
11.5 Malvern Instruments (UK)
11.5.1 Company Details
11.5.2 Exosome Diagnostics and Therapeutics Product Offered
11.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Malvern Instruments (UK) News
11.6 System Biosciences(US)
11.6.1 Company Details
11.6.2 Exosome Diagnostics and Therapeutics Product Offered
11.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 System Biosciences(US) News
11.7 NX Pharmagen (US)
11.7.1 Company Details
11.7.2 Exosome Diagnostics and Therapeutics Product Offered
11.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 NX Pharmagen (US) News
11.8 Sistemic Inc(UK)
11.8.1 Company Details
11.8.2 Exosome Diagnostics and Therapeutics Product Offered
11.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Sistemic Inc(UK) News
11.9 Capricor Therapeutics (US)
11.9.1 Company Details
11.9.2 Exosome Diagnostics and Therapeutics Product Offered
11.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Capricor Therapeutics (US) News
11.10 Exiqon A/S (Denmark)
11.10.1 Company Details
11.10.2 Exosome Diagnostics and Therapeutics Product Offered
11.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Exiqon A/S (Denmark) News

12 Research Findings and Conclusion